Papers

2

Total Citations

17

H-Index

2

About

Jiansong Wang is a pioneering researcher at the intersection of surgical robotics and soft robotic systems, making significant contributions to both clinical urology and robotic design. In the medical domain, Wang is best known for advancing robot-assisted radical cystectomy (RARC), particularly through a landmark 2024 systematic review and meta-analysis comparing intracorporeal urinary diversion (iRARC) with open surgery. This work, cited 13 times, provides crucial evidence on perioperative outcomes and safety, helping to resolve ongoing debates about the superiority of minimally invasive approaches for bladder cancer treatment. In parallel, Wang has broken new ground in soft robotics with a highly innovative 2024 study on reconfigurable soft linkage robots that employ internal "virtual" joints. This work, cited 4 times, challenges traditional distinctions between rigid and soft robots by enabling continuous, flexible movement without discrete mechanical joints—a paradigm shift for adaptable robotic systems. Wang’s dual expertise bridges clinical impact and fundamental engineering, demonstrating how bio-inspired design can transform both surgical practice and robotic hardware. Their research is widely read by urologists and roboticists alike, positioning Wang as a rising interdisciplinary leader whose work promises safer surgeries and more versatile robots.

Research Focus

Key Achievements

2
H-Index
2
Papers
17
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted radical cystectomy with intracorporeal urinary diversion: an updated systematic review and meta-analysis of its differential effect on effectiveness and safety
13 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Kunming Medical University, University of California San Diego

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago